165 related articles for article (PubMed ID: 15834087)
1. Threshold Amsler grid as a screening tool for asymptomatic patients on hydroxychloroquine therapy.
Almony A; Garg S; Peters RK; Mamet R; Tsong J; Shibuya B; Kitridou R; Sadun AA
Br J Ophthalmol; 2005 May; 89(5):569-74. PubMed ID: 15834087
[TBL] [Abstract][Full Text] [Related]
2. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
3. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
Marmor MF; Melles RB
Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Hydroxychloroquine Retinopathy.
Eldeeb M; Chan EW; Omar A
Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487
[TBL] [Abstract][Full Text] [Related]
5. Utility of red amsler grid screening in a rheumatology clinic.
Pluenneke AC; Blomquist PH
J Rheumatol; 2004 Sep; 31(9):1754-5. PubMed ID: 15338495
[TBL] [Abstract][Full Text] [Related]
6. Comparison of threshold and standard Amsler grid testing in patients with established antimalarial retinopathy.
Easterbrook M
Can J Ophthalmol; 1992 Aug; 27(5):240-2. PubMed ID: 1393810
[TBL] [Abstract][Full Text] [Related]
7. Threshold Amsler grid testing in diabetic retinopathy.
Wolfe KA; Sadun AA
Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):219-23. PubMed ID: 1869055
[TBL] [Abstract][Full Text] [Related]
8. The sensitivity of Amsler grid testing in early chloroquine retinopathy.
Easterbrook M
Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():204-7. PubMed ID: 3857780
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine screening.
Lee AG
Br J Ophthalmol; 2005 May; 89(5):521-2. PubMed ID: 15834072
[No Abstract] [Full Text] [Related]
10. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
Chew AL; Sampson DM; Chelva E; Khan JC; Chen FK
Doc Ophthalmol; 2018 Feb; 136(1):57-68. PubMed ID: 29124422
[TBL] [Abstract][Full Text] [Related]
11. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
Maturi RK; Yu M; Weleber RG
Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
[TBL] [Abstract][Full Text] [Related]
12. Entoptic perimetry screening for central diabetic scotomas and macular edema.
Brown JC; Kylstra JA; Mah ML
Ophthalmology; 2000 Apr; 107(4):755-9. PubMed ID: 10768339
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity secondary to Plaquenil therapy.
Hanna B; Holdeman NR; Tang RA; Schiffman JS
Optometry; 2008 Feb; 79(2):90-4. PubMed ID: 18215798
[TBL] [Abstract][Full Text] [Related]
14. Validity and interpretation of Amsler grid reports.
Schuchard RA
Arch Ophthalmol; 1993 Jun; 111(6):776-80. PubMed ID: 8512478
[TBL] [Abstract][Full Text] [Related]
15. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
Marmor MF; Chien FY; Johnson MW
JAMA Ophthalmol; 2013 Apr; 131(4):476-80. PubMed ID: 23710501
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity.
Adam MK; Covert DJ; Stepien KE; Han DP
Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Amsler grid in screening for chloroquine retinopathy.
Suansilpong A; Uaratanawong S
J Med Assoc Thai; 2010 Apr; 93(4):462-6. PubMed ID: 20462090
[TBL] [Abstract][Full Text] [Related]
18. Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity.
Martínez-Costa L; Victoria Ibañez M; Murcia-Bello C; Epifanio I; Verdejo-Gimeno C; Beltrán-Catalán E; Marco-Ventura P
Can J Ophthalmol; 2013 Oct; 48(5):400-5. PubMed ID: 24093187
[TBL] [Abstract][Full Text] [Related]
19. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
Michaelides M; Stover NB; Francis PJ; Weleber RG
Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626
[TBL] [Abstract][Full Text] [Related]
20. Threshold Amsler grid testing in maculopathies.
Wall M; May DR
Ophthalmology; 1987 Sep; 94(9):1126-33. PubMed ID: 3684230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
